Market Overview

UPDATE: Forest Laboratories Posts Q3 Loss

Related FRX
Icahn's (Potential) Move Into Biotech
Carl Icahn's Track Record In Big Pharma

Forest Laboratories (NYSE: FRX) posted a loss in the third quarter.

Forest Laboratories posted a quarterly loss of $153.6 million, or $0.58 per share, versus a year-ago profit of $278.4 million, or $1.04 per share. Its adjusted loss came in at $0.21 per share.

Its net revenue declined to $722.7 million from $1.21 billion. However, analysts were expecting a loss of $0.11 per share.

Forest Labs projects FY13 adjusted profit to be at the lower end of its earlier view of $0.45 to $0.60 per share.

Forest Laboratories shares closed a $37.59 yesterday.

Posted-In: lossEarnings News Guidance


Related Articles (FRX)

View Comments and Join the Discussion!